These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of beta blockers in open angle glaucoma. Marmion VJ Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867 [No Abstract] [Full Text] [Related]
4. Allergic contact dermatitis from carteolol and timolol in eyedrops. Quiralte J; Florido F; de San Pedro BS Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865 [No Abstract] [Full Text] [Related]
5. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2. Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S Arzneimittelforschung; 2006; 56(12):820-5. PubMed ID: 17260669 [No Abstract] [Full Text] [Related]
6. [The therapeutic efficacy of Arutimol in open-angle glaucoma]. Kashintseva LT; Krivitskiĭ AK Oftalmol Zh; 1989; (8):507. PubMed ID: 2576876 [No Abstract] [Full Text] [Related]
7. [Pindolol eye drops - a new beta receptor blockader in the therapy of open-angle glaucoma. Comparative study of 4 weeks' duration]. Heckenhahn K; Levermann H; Tauchert A; Wolf H Med Welt; 1983 Jun; 34(23):676-8. PubMed ID: 6877080 [No Abstract] [Full Text] [Related]
8. [Tolerance and tachyphylaxis during the long-term local treatment of different forms of glaucoma with Arutimol]. Tost M; Herde J; Fincke S; Nook O Oftalmol Zh; 1989; (8):506-7. PubMed ID: 2576875 [No Abstract] [Full Text] [Related]
9. Peyronie's disease following long-term use of topical timolol. Ross JJ; Rahman I; Walters RF Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480 [No Abstract] [Full Text] [Related]
10. Timolol for glaucoma. Singh D Indian J Ophthalmol; 1982 Jul; 30(4):227-8. PubMed ID: 6131866 [No Abstract] [Full Text] [Related]
11. Open-angle glaucoma and cardiovascular mortality. Meyer NI Ophthalmology; 2007 Feb; 114(2):392. PubMed ID: 17270687 [No Abstract] [Full Text] [Related]
12. [Additional experience with the beta blocker befunolol (Glaukonex) in open-angle glaucoma over a period of 1 year]. Merté HJ; Stryz JR Klin Monbl Augenheilkd; 1984 Apr; 184(4):316-7. PubMed ID: 6144813 [TBL] [Abstract][Full Text] [Related]
13. Topical beta-adrenergic blockers and glaucoma: a heart-stopping association? Lama PJ Ophthalmology; 2006 Jul; 113(7):1067-8. PubMed ID: 16815395 [No Abstract] [Full Text] [Related]
14. [Beta-stimulants and beta-blockers. Their role in the medical treatment of open-angle glaucoma]. Weekers R; Collignon-Brach J J Fr Ophtalmol; 1981; 4(2):149-55. PubMed ID: 6113257 [No Abstract] [Full Text] [Related]
16. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111 [TBL] [Abstract][Full Text] [Related]
17. [Value of timoptol in primary open-angle glaucoma patients over 60. Comments on 100 cases]. Clergeau G; Pechereau A Bull Soc Ophtalmol Fr; 1981 Dec; 81(12):1195-9. PubMed ID: 7044586 [No Abstract] [Full Text] [Related]
18. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]